Robert A. Somer

2.4k total citations · 1 hit paper
34 papers, 1.3k citations indexed

About

Robert A. Somer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert A. Somer has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Robert A. Somer's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers) and Brain Metastases and Treatment (4 papers). Robert A. Somer is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers) and Brain Metastases and Treatment (4 papers). Robert A. Somer collaborates with scholars based in United States, United Kingdom and Germany. Robert A. Somer's co-authors include Elyce Cardonick, Marc E. Lippman, Luc Dirix, H. Grote, Kevin M. Chin, Hendrik‐Tobias Arkenau, Petros Nikolinakos, Borys Hrinczenko, Guy Jérusalem and Ralph V. Boccia and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert A. Somer

33 papers receiving 1.2k citations

Hit Papers

Avelumab, an anti-PD-L1 antibody, in patients with locall... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
    2017 581 citations Luc Dirix, István Takács et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Somer United States 15 946 417 255 220 215 34 1.3k
Elżbieta Nowara Poland 18 526 0.6× 173 0.4× 104 0.4× 220 1.0× 359 1.7× 70 1.0k
Paul Richards United States 20 869 0.9× 266 0.6× 138 0.5× 342 1.6× 281 1.3× 42 1.4k
Yukinori Murata Japan 15 841 0.9× 381 0.9× 268 1.1× 169 0.8× 318 1.5× 22 1.3k
S. David Nathanson United States 19 642 0.7× 159 0.4× 150 0.6× 344 1.6× 235 1.1× 41 1.2k
Isabelle Veys Belgium 19 908 1.0× 228 0.5× 339 1.3× 483 2.2× 278 1.3× 67 1.5k
Shih‐Feng Cho Taiwan 20 674 0.7× 114 0.3× 268 1.1× 177 0.8× 530 2.5× 70 1.3k
Lisa M. Cordes United States 20 1.2k 1.2× 412 1.0× 522 2.0× 124 0.6× 308 1.4× 105 1.6k
Hester van Cruijsen Netherlands 16 389 0.4× 227 0.5× 224 0.9× 137 0.6× 351 1.6× 23 962
Carla Casulo United States 19 1.1k 1.1× 147 0.4× 400 1.6× 110 0.5× 244 1.1× 95 1.9k
Tong-Yu Lin China 22 586 0.6× 163 0.4× 237 0.9× 133 0.6× 444 2.1× 47 1.3k

Countries citing papers authored by Robert A. Somer

Since Specialization
Citations

This map shows the geographic impact of Robert A. Somer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Somer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Somer more than expected).

Fields of papers citing papers by Robert A. Somer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Somer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Somer. The network helps show where Robert A. Somer may publish in the future.

Co-authorship network of co-authors of Robert A. Somer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Somer. A scholar is included among the top collaborators of Robert A. Somer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Somer. Robert A. Somer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linghu, Bolan, Robert A. Somer, Shalaka Hampras, et al.. (2024). Treatment patterns with intravesical bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC): A real-world data analysis.. Journal of Clinical Oncology. 42(16_suppl). e16584–e16584. 1 indexed citations
2.
3.
Davis, William, et al.. (2019). Next-Generation Sequencing in 305 Consecutive Patients: Clinical Outcomes and Management Changes. Journal of Oncology Practice. 15(12). e1028–e1034. 11 indexed citations
4.
Dirix, Luc, István Takács, Guy Jérusalem, et al.. (2017). Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Breast Cancer Research and Treatment. 167(3). 671–686. 581 indexed citations breakdown →
5.
Somer, Robert A., et al.. (2017). Metastatic Renal Cell Carcinoma to Jejunum: An Unusual Case Presentation. Urology Case Reports. 13. 34–36. 3 indexed citations
6.
Somer, Robert A., et al.. (2017). Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution. Molecular Cancer Research. 15(9). 1127–1137. 34 indexed citations
7.
Somer, Robert A., et al.. (2017). Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. 15(5). e847–e849. 24 indexed citations
8.
Ferrari, Alessio, G. R. Hudes, Michael A. Carducci, et al.. (2016). E2809. Androgen receptor (AR) modulation by bicalutamide (Bic) and MK-2206 (MK) in prostate cancer (PC) patients (pts) with rising PSA at high risk of progression after local treatment (tx). Annals of Oncology. 27. vi249–vi249. 1 indexed citations
9.
Turtz, Alan, et al.. (2016). Effects of whole brain radiation on blood counts. 7(1). 2 indexed citations
10.
Kubicek, Gregory J., et al.. (2016). Brain Metastasis Responsive to Pazopanib in Renal Cell Carcinoma: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. 14(4). e401–e404. 9 indexed citations
11.
Esteva, Francisco J., Sandra Franco, Abenaa M. Brewster, et al.. (2013). An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer. The Oncologist. 18(6). 661–666. 15 indexed citations
12.
Cardonick, Elyce, et al.. (2012). Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Annals of Oncology. 23(12). 3016–3023. 86 indexed citations
13.
Cardonick, Elyce, et al.. (2012). Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy. Obstetrics and Gynecology. 120(6). 1267–1272. 55 indexed citations
14.
15.
Stevenson, James, Corey J. Langer, Robert A. Somer, et al.. (2012). Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer. Cancer. 118(22). 5580–5587. 19 indexed citations
16.
Somer, Robert A., et al.. (2011). Novel Approach to Gorlin Syndrome:A Patient Treated With Oral Capecitabine. Journal of Clinical Oncology. 29(14). e397–e401. 17 indexed citations
17.
Somer, Robert A., Eric J. Sherman, & Corey J. Langer. (2008). Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599. Clinical Lung Cancer. 9(2). 102–105. 23 indexed citations
18.
Langer, Corey J., Robert A. Somer, Samuel Litwin, et al.. (2007). Phase I Study of Radical Thoracic Radiation, Weekly Irinotecan, and Cisplatin in Locally Advanced Non-small Cell Lung Carcinoma. Journal of Thoracic Oncology. 2(3). 203–209. 7 indexed citations
19.
Tang, Yong, et al.. (2004). Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format. Journal of Biological Chemistry. 279(52). 53907–53914. 95 indexed citations
20.
Adonizio, Christian S., James S. Babb, Chao Huang, et al.. (2002). Temozolomide in Non—Small-Cell Lung Cancer: Preliminary Results of a Phase II Trial in Previously Treated Patients. Clinical Lung Cancer. 3(4). 254–258. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elżbieta Nowara Breakdown of academic impact, for papers by Paul Richards Breakdown of academic impact, for papers by Yukinori Murata Breakdown of academic impact, for papers by S. David Nathanson Breakdown of academic impact, for papers by Isabelle Veys Breakdown of academic impact, for papers by Shih‐Feng Cho Breakdown of academic impact, for papers by Lisa M. Cordes Breakdown of academic impact, for papers by Hester van Cruijsen Breakdown of academic impact, for papers by Carla Casulo Breakdown of academic impact, for papers by Tong-Yu Lin
Rankless by CCL
2026